Emsita-D Tablet contains Dapagliflozin and Sitagliptin, a combination medication used to help manage blood glucose levels in individuals with diabetes. Dapagliflozin helps lower blood sugar by preventing the kidneys from reabsorbing glucose and allowing excess sugar to be eliminated through urine. Sitagliptin works by enhancing the activity of incretin hormones that regulate insulin release and decrease glucose production after meals. Together these medicines help improve blood sugar control and support stable glucose levels. Maintaining proper blood glucose levels is essential for preventing complications related to diabetes and supporting overall metabolic health. The medicine is usually taken according to the dosage recommended by a healthcare professional. Along with medication, lifestyle changes such as healthy diet and regular physical activity can improve treatment outcomes. When used consistently as prescribed, Emsita-D Tablet helps support effective diabetes management and better metabolic balance.